Can IPCA Break the trend?Ipca Laboratories Ltd. engages in the manufacturing, marketing, research, and development of pharmaceutical products. Its products include Hydroxychloroquine Sulphate, Artemether and Lumefantrine and Acceclofenac and its combinations. The Company has 18 manufacturing units in India manufacturing API's and formulations for the world market.
Ipca Laboratories Ltd CMP 1220.75. The positive aspects of the company are Mutual Funds Increased Shareholding in Past Month, Company with Low Debt, Company with Zero Promoter Pledge and FII / FPI or Institutions increasing their shareholding. The Negative aspects of the company are High PE (PE=56.6), MFs decreased their shareholding last quarter, Declining Net Cash Flow : Companies not able to generate net cash and De-growth in Revenue, Profits and Operating Profit Margin in recent results.
Entry can be taken after closing above 1225. Targets in the stock will be 1252 and 1294. The long-term target in the stock will be 1328 and 1357. Stop loss in the stock should be maintained at Closing below 1136.
The above information is provided for educational purpose, analysis and paper trading only. Please don't treat this as a buy or sell recommendation for the stock. We do not guarantee any success in highly volatile market or otherwise. Stock market investment is subject to market risks which include global and regional risks. We will not be responsible for any Profit or loss that may occur due to any financial decision taken based on any data provided in this message.
IPCALAB
Keep An Eye - IPCALAB📊 Script: IPCALAB
📊 Sector: Pharmaceuticals
📊 Industry: Pharmaceuticals - Indian - Bulk Drugs
Key highlights: 💡⚡
📈 Keep An Eye on Script, it is trading near its resistance level which is 1248 and may give breakout of it.
📈 Script is trading at upper band of BB.
📈 MACD is giving crossover.
📈 Double Moving Averages are also giving crossover.
📈 Right now RSI is around 62.
📈 One can go for Swing Trade only above 1248 level.
BUY ONLY ABOVE 1248
⏱️ C.M.P 📑💰- 1237
🟢 Target 🎯🏆 - 1317
⚠️ Stoploss ☠️🚫 - 1198
⚠️ Important: Always maintain your Risk & Reward Ratio.
✅Like and follow to never miss a new idea!✅
Disclaimer: I am not SEBI Registered Advisor. My posts are purely for training and educational purposes.
Eat🍜 Sleep😴 TradingView📈 Repeat 🔁
Happy learning with trading. Cheers!🥂
#IPCALAB Stock looks good for another 20-25% move above. #IPCALAB
Stock looks good for another 20-25% move above.
A candle close below ₹1100 would trigger me to close the position.
1) There is a bullish pennant forming with measured target of above ₹1400
2) Horizontal previous ATH support - Looks great.
#KIRLPNU 660 Tgt 800 21% Buy-Rachit Sethia #Kirloseng #kirloskarKIRLPNU 660
TGT 800
SL 600
RR > 2.4
Return >21%
TF < 6M
Factors: BULLISH WEDGE BREAKOUT Trend Following Rising Volume with rising Prices. Flag pattern breakout. Pennant Pattern Breakout with Bullish Candle. Retest Successful. Higher Highs & Higher Lows. Broken above RESISTANCE levels Trading at SUPPORT levels Earnings are strong. Bullish Wedge Breakout Risk Return Ratio is healthy. And Rising from Double Bottom Pattern to Flag Pattern forming. If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations. With 💚 from Rachit Sethia
IPCALAB Low Risk Big Profit IdeaAs per my analysis, 707 level was strong resistance of NSE:IPCALAB . Now resistance has been brake and sustained above 707. My idea is to take buy entry at level of 707 with stop loss of 666 (-41 Points Risk). My expected upside target would be 766 (+59) & 966 (+259 Points).
It could be jackpot idea.
Note: This is my personal analysis, only to learn stock market behavior. Thanks.
#IPCALAB #MOREPENLAB #DRREDDY #LAURUSLABS #DIVISLABS #AUROPHARMA#IPCALAB
NSE: IPCALAB
CMP: 864
TP: 980
SL: 840
TF: <6m
RR > ~4.5 times
Return > 13%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#LALPATHLAB #MOREPENLAB #IPCALAB #DIVISLAB #VIMTALAB #LAURUSLABS#LALPATHLAB
NSE: LALPATHLAB
CMP: 2345
TP: 3075
SL: 2100
TF: <6m
RR > ~3 times
Return > 30%
THYROCARE CNXPHARMA LUPIN SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE APOLLOHOSP FORTIS AARTIDRUGS ZYDUSWELL MAXHEALTH BAJAJHCARE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
#BIOCON #LUPIN #DIVISLAB #ALKEM #IPCALAB #GRANULES #AUROPHARMA#BIOCON
NSE: BIOCON
CMP: 267
TP: 320
SL: 250
TF: <6m
RR > 4 times
Return > 20%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
#vimtalabs #ipcalab #lauruslabs #lalpathlab #guficbio #alkem#VIMTALABS
NSE: VIMTALABS
CMP: 461
TP: 560
SL: 410
TF: <6m
RR > 2 times
Return > 22%
THYROCARE CNXPHARMA LUPIN NSE:CIPLA SUNPHARMA SPARC DIVISLAB DRREDDY AUROPHARMA BALPHARMA GLENMARK SANOFI PFIZER BPLPHARMA MARKSANS BIOCON GRANULES IPCALAB LAURUSLABS NATCOPHARM GLAND ALKEM ZYDUSLIFE
Factors:
BULLISH WEDGE BREAKOUT
Trend Following
Rising Volume with rising Prices.
Flag pattern breakout.
Pennant Pattern Breakout with Bullish Candle.
Retest Successful.
Higher Highs & Higher Lows.
Broken above RESISTANCE levels
Trading at SUPPORT levels
Earnings are strong.
Bullish Wedge Breakout
Risk Return Ratio is healthy.
And
Rising from Double Bottom Pattern to Flag Pattern forming.
If you like my work KINDLY LIKE SHARE & FOLLOW this page for free Stock Recommendations.
With 💚 from Rachit Sethia
IPCALAB - Bullish engulfingA bullish engulfing candle has been formed on the daily time frame suggesting a good move in the upward direct is very much possible.
There is a good consolidation zone being formed and a breach of the zone(resistance) would surely give a good upward movement in this counter.
For buying the stock should be trading above the levels of 1069 and on the other hand if prices fall below 1056 we could see support areas.
Do not look at the huge red candle as that was the stock split.
Above the zone any big buying that happens will take the price up.
All the best
Your feedback is highly appreciated
Buy IPCA for target 1730 with stop loss 1583 IPCA will not only survive , but outperforme other stocks. World is falling because of the fear of poor Q1 results. On the other hand , IPCA will have Huge growth in profits.
*IPCA LAB RS 36.31 CRS NSE BLOCK TRADE FOR~ 224839 SHARES, AT RS 1615* #IPCALAB - on 30th april